Preliminary evidence of improved liver biomarkers in adolescents with obesity and suspected metabolic dysfunction‐associated steatotic liver disease treated with semaglutide: A case series

Documenti analoghi

• Interferon‐gamma blocking as a promising treatment for severe liver dysfunction in secondary hemophagocytic lymphohistiocytosis after liver transplantation
  di: Chen Chen, et al.
  Pubblicazione: (2025)
• Hepatopulmonary syndrome as presentation of pediatric metabolic dysfunction‐associated steatohepatitis
  di: Shruti Sakhuja, et al.
  Pubblicazione: (2026)
• Letter to the editor: A response to Hildreth and Schwimmer
  di: Rachel B. Schenker, et al.
  Pubblicazione: (2024)
• Odevixibat as an adjunctive treatment for refractory pruritus in rare variants of cholestatic liver disease
  di: Akshat Goel, et al.
  Pubblicazione: (2024)
• The first paediatric living donor auxiliary orthotopic liver transplant for dengue acute liver failure
  di: Somashekara Hosaagrahara Ramakrishna, et al.
  Pubblicazione: (2024)